Heron Therapeutics News

Here's What Analysts Are Forecasting For Heron Therapeutics, Inc. (NASDAQ:HRTX) After Its First-Quarter Results

Heron Therapeutics, Inc. (NASDAQ:HRTX) just released its latest first-quarter results and things are looking bullish. Results overall were solid, with revenues arriving 5.1% better than analyst f

Simply Wall StMay 9 18:25

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 00:30

Needham: Reiterates Heron Therapeutics (HRTX.US) rating, adjusted from buy to buy rating, target price of $5.00.

Needham: Reiterates Heron Therapeutics (HRTX.US) rating, adjusted from buy to buy rating, target price of $5.00.

Zhitong FinanceMay 8 17:40

Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

BenzingaMay 8 17:35

Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant ...

Yahoo FinanceMay 8 15:10

Q1 2024 Heron Therapeutics Inc Earnings Call

Yahoo FinanceMay 8 11:00

Earnings Call Summary | Heron Therapeutics(HRTX.US) Q1 2024 Earnings Conference

The following is a summary of the Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript:Financial Performance:Heron Therapeutics Q1 net revenue was $34.6 million, up from $29.6 million year

Futu NewsMay 8 05:38 · Conference Call

Heron Therapeutics: A Strong Buy on Surging Sales and Strategic Partnerships

TipRanksMay 8 02:56

Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript

Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 8 02:38

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say

Yahoo FinanceMay 7 21:30

Heron Therapeutics Inc. Q1 Loss Decreases, Beats Estimates

RTTNewsMay 7 20:28

Heron Therapeutics | 10-Q: Quarterly report

Futu NewsMay 7 20:09 · Announcements

Heron Therapeutics Reaffirms FY24 Revenue $138.0M-$158.0M Vs $144.875M Est.

Heron Therapeutics Reaffirms FY24 Revenue $138.0M-$158.0M Vs $144.875M Est.

BenzingaMay 7 20:03

Press Release: Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates PR Newswire SAN DIEGO, May 7, 2024 -- Net Product Sales of $34.7 million, which increase

Dow JonesMay 7 20:01

Heron Therapeutics 1Q Loss/Shr 2c >HRTX

Heron Therapeutics 1Q Loss/Shr 2c >HRTX

Dow JonesMay 7 20:00

Institutional Investors Are Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Biggest Bettors and Were Rewarded After Last Week's US$51m Market Cap Gain

Key Insights Given the large stake in the stock by institutions, Heron Therapeutics' stock price might be vulnerable to their trading decisions A total of 9 investors have a majority stake in the co

Simply Wall StMay 7 19:00

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

SAN DIEGO, April 24, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webc

PR NewswireApr 24 20:00

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s

BenzingaApr 24 01:53

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Tuesday.Shares of HealthStream, Inc. (NASDAQ:HSTM) rose sharply during Tuesday's session following upbeat quarterly result

BenzingaApr 23 22:50

Heron Therapeutics Initiated at Overweight by Capital One

Heron Therapeutics Initiated at Overweight by Capital One

Dow JonesApr 23 19:22